European Equities Retreat as Investors Await Fed Minutes and UK Inflation Data

European equity markets ended the session in the red, characterized by a lack of conviction as traders braced for key macroeconomic catalysts. The pan-European Stoxx 600 declined by 0.18%, reflecting a broader trend of hesitation across the continent. The cautious mood was driven primarily by anticipation of the Federal Reserve's latest policy meeting minutes and the forthcoming April inflation report from the UK. This 'wait-and-see' approach saw the CAC 40 lead the losses among major indices, dropping 0.67%, while the DAX and FTSE 100 saw more modest declines of 0.22% and 0.09%, respectively. Individual corporate news provided some pockets of strength. AstraZeneca shares climbed 2.25% following the company's announcement of a total revenue target of $80 billion by 2030. In Germany, defense contractor Rheinmetall rallied nearly 3%. Conversely, BT Group faced selling pressure, falling approximately 3.2%. Economic indicators presented a mixed picture. The European Central Bank reported that the euro area's current account surplus rose to EUR 36 billion in March, up from EUR 29 billion in February. Meanwhile, German producer prices fell 3.3% year-on-year in April, slightly exceeding economist expectations of a 3.2% decline. The overall session suggests a period of consolidation. With construction output in the Eurozone growing at a slower pace of 0.1% in March, the market remains sensitive to signs of economic stagnation and the trajectory of global interest rates.